These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23041831)

  • 1. Mitotic figure counts are significantly overestimated in resection specimens of invasive breast carcinomas.
    Lehr HA; Rochat C; Schaper C; Nobile A; Shanouda S; Vijgen S; Gauthier A; Obermann E; Leuba S; Schmidt M; C CR; Delaloye JF; Simiantonaki N; Schaefer SC
    Mod Pathol; 2013 Mar; 26(3):336-42. PubMed ID: 23041831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of proliferative activity in breast cancer: MIB-1 immunohistochemistry versus mitotic figure count.
    Lehr HA; Hansen DA; Kussick S; Li M; Hwang H; Krummenauer F; Trouet S; Gown AM
    Hum Pathol; 1999 Nov; 30(11):1314-20. PubMed ID: 10571511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proliferation markers in breast carcinoma. Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1.
    Keshgegian AA; Cnaan A
    Am J Clin Pathol; 1995 Jul; 104(1):42-9. PubMed ID: 7611179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitotic counts in one high power field in breast core biopsies is equivalent to counts in 10 high power fields.
    Lee W; Law T; Lu Y; Lee TK; Ibarra JA
    Pathology; 2022 Feb; 54(1):43-48. PubMed ID: 34916071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of Ki-67 antigen expression with mitotic figure index and tumor grade in breast carcinomas using the novel "paraffin"-reactive MIB1 antibody.
    Weidner N; Moore DH; Vartanian R
    Hum Pathol; 1994 Apr; 25(4):337-42. PubMed ID: 8163266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitotic index matter: how to improve the assessment of mitosis in order to better classify G2 breast cancer and luminal A category.
    Del Sordo R; Bellezza G; Ferri I; Pireddu A; Colella R; Sidoni A
    Histol Histopathol; 2018 Jan; 33(1):81-88. PubMed ID: 28332699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grading system for blood vessel tumor emboli of invasive ductal carcinoma of the breast.
    Sugiyama M; Hasebe T; Shimada H; Takeuchi H; Shimizu K; Shimizu M; Yasuda M; Ueda S; Shigekawa T; Osaki A; Saeki T
    Hum Pathol; 2015 Jun; 46(6):906-16. PubMed ID: 25890786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histological grade of invasive carcinoma of the breast assessed on needle core biopsy - modifications to mitotic count assessment to improve agreement with surgical specimens.
    O'Shea AM; Rakha EA; Hodi Z; Ellis IO; Lee AH
    Histopathology; 2011 Sep; 59(3):543-8. PubMed ID: 21906126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MIB-1 (Ki-67) immunostaining of breast cancer cells in cytologic smears.
    Dalquen P; Baschiera B; Chaffard R; Dieterich H; Feichter GE; Krmer K; Torhorst J
    Acta Cytol; 1997; 41(2):229-37. PubMed ID: 9100748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Grading system for lymph vessel tumor emboli for prediction of the outcome of invasive ductal carcinoma of the breast.
    Hasebe T; Yamauchi C; Iwasaki M; Ishii G; Wada N; Imoto S
    Hum Pathol; 2008 Mar; 39(3):427-36. PubMed ID: 18261627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy and efficiency of an artificial intelligence tool when counting breast mitoses.
    Pantanowitz L; Hartman D; Qi Y; Cho EY; Suh B; Paeng K; Dhir R; Michelow P; Hazelhurst S; Song SY; Cho SY
    Diagn Pathol; 2020 Jul; 15(1):80. PubMed ID: 32622359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of fixation delay on mitotic activity and flow cytometric cell cycle variables.
    Bergers E; Jannink I; van Diest PI; Cuesta MA; Meyer S; van Mourik JC; Baak JP
    Hum Pathol; 1997 Jan; 28(1):95-100. PubMed ID: 9013839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value.
    Spyratos F; Ferrero-Poüs M; Trassard M; Hacène K; Phillips E; Tubiana-Hulin M; Le Doussal V
    Cancer; 2002 Apr; 94(8):2151-9. PubMed ID: 12001111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of mitotic figures in metastatic mammary ductal carcinoma to the lymph nodes.
    Hasebe T; Iwasaki M; Akashi-Tanaka S; Hojo T; Shibata T; Sasajima Y; Kinoshita T; Tsuda H
    Hum Pathol; 2011 Dec; 42(12):1823-32. PubMed ID: 21683981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative study of two complementary proliferation markers in 200 breast carcinomas: Ki67 and mitotic index.
    El Amine O; Ouni R; Adouni O; Goucha A; Ben Hassouna J; Rahal K; El May A; Gamoudi A
    Tunis Med; 2016 Oct; 94(8-9):587-593. PubMed ID: 28685793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of two complementary proliferation markers in 200 breast carcinomas: Ki67 and mitotic index.
    El Amine O; Ouni R; Adouni O; Goucha A; Ben Hassouna J; Rahal K; El May A; Gamoudi A
    Tunis Med; 2016 Oct; 94(10):587-593. PubMed ID: 28972249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visual assessment of Ki67 using a 5-grade scale (Eye-5) is easy and practical to classify breast cancer subtypes with high reproducibility.
    Hida AI; Bando K; Sugita A; Maeda T; Ueda N; Matsukage S; Nakanishi M; Kito K; Miyazaki T; Ohtsuki Y; Oshiro Y; Inoue H; Kawaguchi H; Yamashita N; Aogi K; Moriya T
    J Clin Pathol; 2015 May; 68(5):356-61. PubMed ID: 25673730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative thresholds for mitotic counts in histologic grading: confirmation in nonfrozen samples of invasive ductal breast cancer.
    Kronqvist P; Kuopio T; Collan Y
    Ann Diagn Pathol; 2000 Apr; 4(2):65-70. PubMed ID: 10760318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine 2481-autophosphorylation of mammalian target of rapamycin (mTOR) couples with chromosome condensation and segregation during mitosis: confocal microscopy characterization and immunohistochemical validation of PP-mTOR(Ser2481) as a novel high-contrast mitosis marker in breast cancer core biopsies.
    Lopez-Bonet E; Vazquez-Martin A; Pérez-Martínez MC; Oliveras-Ferraros C; Pérez-Bueno F; Bernadó L; Menendez JA
    Int J Oncol; 2010 Jan; 36(1):107-15. PubMed ID: 19956839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving mitotic cell counting accuracy and efficiency using phosphohistone-H3 (PHH3) antibody counterstained with haematoxylin and eosin as part of breast cancer grading.
    Ibrahim A; Toss MS; Makhlouf S; Miligy IM; Minhas F; Rakha EA
    Histopathology; 2023 Feb; 82(3):393-406. PubMed ID: 36349500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.